Wed, February 16, 2022
Tue, February 15, 2022
Mon, February 14, 2022

Madhu Kumar Initiated (SNDX) at Strong Buy and Held Target at $37 on, Feb 15th, 2022

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-37-on-feb-15th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Madhu Kumar of Goldman Sachs, Initiated "Syndax Pharmaceuticals, Inc." (SNDX) at Strong Buy and Held Target at $37 on, Feb 15th, 2022.

Madhu, nor any peers, have made any analyst calls on SNDX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30